Pub. Date : 2019 Sep
PMID : 31656659
4 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Real world experience on treatment, outcome and toxicity of crizotinib in patients with anaplastic lymphoma kinase positive advanced non-small cell lung cancer. | crizotinib | ALK receptor tyrosine kinase | Homo sapiens |
| 2 | Background: Crizotinib has been the standard treatment for patients with anaplastic lymphoma kinase (ALK)-rearranged advanced non-small cell lung cancer (NSCLC). | crizotinib | ALK receptor tyrosine kinase | Homo sapiens |
| 3 | Background: Crizotinib has been the standard treatment for patients with anaplastic lymphoma kinase (ALK)-rearranged advanced non-small cell lung cancer (NSCLC). | crizotinib | ALK receptor tyrosine kinase | Homo sapiens |
| 4 | Conclusions: This retrospective analysis of a real-world experience confirms the therapeutic benefit of crizotinib in advanced ALK-positive NSCLC. | crizotinib | ALK receptor tyrosine kinase | Homo sapiens |